Log in

NASDAQ:LEGNLegend Biotech Stock Price, Forecast & News

$39.20
-3.36 (-7.89 %)
(As of 07/1/2020 04:00 PM ET)
Add
Today's Range
$38.54
Now: $39.20
$43.24
50-Day Range N/A
52-Week Range
$35.00
Now: $39.20
$43.24
Volume706,760 shs
Average Volume417,147 shs
Market Capitalization$5.07 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:LEGN
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees650
Market Cap$5.07 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive LEGN News and Ratings via Email

Sign-up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.

Legend Biotech (NASDAQ:LEGN) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Legend Biotech?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Legend Biotech in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Legend Biotech.

What price target have analysts set for LEGN?

3 analysts have issued 12 month price objectives for Legend Biotech's shares. Their forecasts range from $47.00 to $55.00. On average, they expect Legend Biotech's share price to reach $50.67 in the next year. This suggests a possible upside of 29.3% from the stock's current price. View analysts' price targets for Legend Biotech.

Has Legend Biotech been receiving favorable news coverage?

News coverage about LEGN stock has been trending very negative recently, according to InfoTrie. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Legend Biotech earned a news impact score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Legend Biotech.

Who are Legend Biotech's key executives?

Legend Biotech's management team includes the following people:
  • Dr. Yuan Xu Ph.D., CEO & Director (Age 52)
  • Dr. Frank Fan M.D., Ph.D., Co-Founder & Chief Scientific Officer
  • Dr. Ying Huang, Chief Financial Officer (Age 46)
  • Dr. Meeta Chatterjee Ph.D., Sr. VP of Global Bus. Devel.
  • Ms. Liz Gosen, Sr. VP of Global Technical Operations

When did Legend Biotech IPO?

(LEGN) raised $350 million in an initial public offering (IPO) on Friday, June 5th 2020. The company issued 18,400,000 shares at a price of $18.00-$20.00 per share. Morgan Stanley, J.P. Morgan Securities and Jefferies served as the underwriters for the IPO.

What is Legend Biotech's stock symbol?

Legend Biotech trades on the NASDAQ under the ticker symbol "LEGN."

When does Legend Biotech's quiet period expire?

Legend Biotech's quiet period expires on Wednesday, July 15th. Legend Biotech had issued 18,425,000 shares in its IPO on June 5th. The total size of the offering was $423,775,000 based on an initial share price of $23.00. During Legend Biotech's quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Legend Biotech?

Shares of LEGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Legend Biotech's stock price today?

One share of LEGN stock can currently be purchased for approximately $39.20.

How big of a company is Legend Biotech?

Legend Biotech has a market capitalization of $5.07 billion. Legend Biotech employs 650 workers across the globe.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.